Literature DB >> 17370541

Questioning aerosol transmission of influenza.

Camille Lemieux, Gabrielle Brankston, Leah Gitterman, Zahir Hirji, Michael Gardam.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17370541      PMCID: PMC2725811          DOI: 10.3201/eid1301.061202

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.

To the Editor

We have reviewed the literature cited in Tellier’s Review of Aerosol Transmission of Influenza A Virus () and disagree that it supports the conclusions drawn regarding the importance of aerosols in natural influenza infection. In certain cited studies, researchers recovered viable virus from artificially generated aerosols; this is not evidence that aerosol transmission leads to natural human infection (,). By standard definitions, the rarity of long-range infections supports the conclusion that effective aerosol transmission is absent in the natural state () (www.cdc.gov/ncidod/dhqp/gl_isolation_hicpac.html). The superior efficacy of inhaled versus intranasal zanamivir is referenced as support for the idea that the lower respiratory tract is the preferred site of influenza infection; however, 1 study cited is insufficiently powered, and the other 2 do not compare the intranasal and inhaled routes (–). The major site of deposition of inhaled zanamivir is the oropharynx (77.6%), not the lungs (13.2%) (www.gsk.ca/en/products/prescription/relenza_pm.pdf). In another flawed study (), study participants naturally infected with wild-type virus are compared with study participants experimentally infected with an attenuated strain. In a review of such relevance, critical analysis of confounding factors is necessary. The Alaska Airlines outbreak () is presented as proof of airborne influenza transmission; however, droplet/contact transmission remains plausible because passenger movement was not restricted and the index patient was seated in high-traffic area. In the Livermore Hospital study (), serious confounders such as bed arrangements, number of influenza exposures, patient mix, and ventilation were not accounted for. We encourage readers of Teller’s article to review the relevant primary literature. We believe that the only reasonable conclusion that can be drawn at this time is that aerosol transmission does not play a major role in natural influenza epidemiology. Whether aerosols play any role in the transmission of influenza is a question demanding an answer; it is clear that we do not yet have that answer. Coughing and sneezing during influenza produce virus-containing aerosols. In the laboratory, influenza virus in homogeneous aerosols, free of large droplets, can infect volunteers at very small doses; studies of infectivity decay in aerosols show persistence for hours. These observations required the generation of artificial aerosols but were performed under conditions that do not enhance stability or virulence (,). Therefore, they have great relevance for natural infections. The scarcity of infections that are transmitted long range in well-ventilated areas does not rule out infectivity of aerosol-size particles near patients. That only 13% of inhaled zanamivir is deposited in the lungs is not important: after inhalation, the zanamivir concentration throughout the respiratory tract is >10 μmol/L, orders of magnitude above the 50% inhibitory concentration (). Intranasal zanamivir is protective against large droplets (), which are trapped in the nose (). The requirement for inhaled zanamivir in natural infections (,) points to aerosol contribution and to the lower respiratory tract as the preferred site. Little et al. () compared the severity of natural illness caused by H3N2 strains from 1974 and 1975 to that caused by experimental intranasal inoculation from H3N2 strains from 1972, 1974, and 1975. The challenge strains underwent few passages; characterizing them as "attenuated" is incorrect. Although large droplets probably accounted for some cases in the Alaska Airlines outbreak (), this outbreak was remarkable for its high attack rate (72%) and for deficient ventilation, which would increase transmission by aerosols but not by large droplets. Passengers with influenza are common, yet with proper ventilation such an attack rate is uncommon. During the Livermore Hospital study (), respiratory infections other than influenza occurred in both groups. It was assumed that visitors and staff would provide equivalent introductions of the virus during the several months of the study; 4 study participants in the irradiated building seroconverted, but the virus did not propagate. The concern by Lemieux and colleagues about ventilation is odd because it would affect mostly aerosol transmission. I concur with encouraging readers to review the original references. They make a compelling case for the importance of aerosol transmission. In contrast, no convincing data rule it out.
  11 in total

1.  Short-term treatment with zanamivir to prevent influenza: results of a placebo-controlled study.

Authors:  L Kaiser; D Henry; N P Flack; O Keene; F G Hayden
Journal:  Clin Infect Dis       Date:  2000-03       Impact factor: 9.079

2.  Routine practices and additional precautions for preventing the transmission of infection in health care.

Authors: 
Journal:  Can Commun Dis Rep       Date:  1999-07

3.  Virus survival as a seasonal factor in influenza and poliomylitis.

Authors:  J H HEMMES; K C WINKLER; S M KOOL
Journal:  Antonie Van Leeuwenhoek       Date:  1962       Impact factor: 2.271

4.  Safety and efficacy of intravenous zanamivir in preventing experimental human influenza A virus infection.

Authors:  D P Calfee; A W Peng; L M Cass; M Lobo; F G Hayden
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

5.  An outbreak of influenza aboard a commercial airliner.

Authors:  M R Moser; T R Bender; H S Margolis; G R Noble; A P Kendal; D G Ritter
Journal:  Am J Epidemiol       Date:  1979-07       Impact factor: 4.897

6.  Attenuated influenza produced by experimental intranasal inoculation.

Authors:  J W Little; R G Douglas; W J Hall; F K Roth
Journal:  J Med Virol       Date:  1979       Impact factor: 2.327

7.  Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group.

Authors:  F G Hayden; L V Gubareva; A S Monto; T C Klein; M J Elliot; J M Hammond; S J Sharp; M J Ossi
Journal:  N Engl J Med       Date:  2000-11-02       Impact factor: 91.245

8.  Pharmacoscintigraphic evaluation of lung deposition of inhaled zanamivir in healthy volunteers.

Authors:  L M Cass; J Brown; M Pickford; S Fayinka; S P Newman; C J Johansson; A Bye
Journal:  Clin Pharmacokinet       Date:  1999       Impact factor: 6.447

9.  Safety and efficacy of once daily intranasal zanamivir in preventing experimental human influenza A infection.

Authors:  D P Calfee; A W Peng; E K Hussey; M Lobo; F G Hayden
Journal:  Antivir Ther       Date:  1999

Review 10.  Review of aerosol transmission of influenza A virus.

Authors:  Raymond Tellier
Journal:  Emerg Infect Dis       Date:  2006-11       Impact factor: 6.883

View more
  27 in total

Review 1.  Cross-species virus transmission and the emergence of new epidemic diseases.

Authors:  Colin R Parrish; Edward C Holmes; David M Morens; Eun-Chung Park; Donald S Burke; Charles H Calisher; Catherine A Laughlin; Linda J Saif; Peter Daszak
Journal:  Microbiol Mol Biol Rev       Date:  2008-09       Impact factor: 11.056

2.  Aerosol influenza transmission risk contours: a study of humid tropics versus winter temperate zone.

Authors:  Brian P Hanley; Birthe Borup
Journal:  Virol J       Date:  2010-05-14       Impact factor: 4.099

3.  Informing optimal environmental influenza interventions: how the host, agent, and environment alter dominant routes of transmission.

Authors:  Ian H Spicknall; James S Koopman; Mark Nicas; Josep M Pujol; Sheng Li; Joseph N S Eisenberg
Journal:  PLoS Comput Biol       Date:  2010-10-28       Impact factor: 4.475

4.  Absolute humidity modulates influenza survival, transmission, and seasonality.

Authors:  Jeffrey Shaman; Melvin Kohn
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-09       Impact factor: 11.205

5.  A schlieren optical study of the human cough with and without wearing masks for aerosol infection control.

Authors:  Julian W Tang; Thomas J Liebner; Brent A Craven; Gary S Settles
Journal:  J R Soc Interface       Date:  2009-10-08       Impact factor: 4.118

6.  Qualitative real-time schlieren and shadowgraph imaging of human exhaled airflows: an aid to aerosol infection control.

Authors:  Julian W Tang; Andre D G Nicolle; Jovan Pantelic; Mingxiu Jiang; Chandra Sekhr; David K W Cheong; Kwok Wai Tham
Journal:  PLoS One       Date:  2011-06-22       Impact factor: 3.240

7.  Reconstructing the 2003/2004 H3N2 influenza epidemic in Switzerland with a spatially explicit, individual-based model.

Authors:  Timo Smieszek; Michael Balmer; Jan Hattendorf; Kay W Axhausen; Jakob Zinsstag; Roland W Scholz
Journal:  BMC Infect Dis       Date:  2011-05-09       Impact factor: 3.090

8.  Exhaled aerosol transmission of pandemic and seasonal H1N1 influenza viruses in the ferret.

Authors:  Frederick Koster; Kristine Gouveia; Yue Zhou; Kristin Lowery; Robert Russell; Heather MacInnes; Zemmie Pollock; R Colby Layton; Jennifer Cromwell; Denise Toleno; John Pyle; Michael Zubelewicz; Kevin Harrod; Rangarajan Sampath; Steven Hofstadler; Peng Gao; Yushi Liu; Yung-Sung Cheng
Journal:  PLoS One       Date:  2012-04-03       Impact factor: 3.240

9.  Large Eddy Simulation of Air Escape through a Hospital Isolation Room Single Hinged Doorway--Validation by Using Tracer Gases and Simulated Smoke Videos.

Authors:  Pekka E Saarinen; Petri Kalliomäki; Julian W Tang; Hannu Koskela
Journal:  PLoS One       Date:  2015-07-07       Impact factor: 3.240

10.  Lack of airborne transmission during outbreak of pandemic (H1N1) 2009 among tour group members, China, June 2009.

Authors:  Ke Han; Xiaoping Zhu; Fan He; Lunguang Liu; Lijie Zhang; Huilai Ma; Xinyu Tang; Ting Huang; Guang Zeng; Bao Ping Zhu
Journal:  Emerg Infect Dis       Date:  2009-10       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.